Ads
related to: eli lilly diabetes drug- Press Releases
Find Press Releases
and News for Lilly.
- Lilly Recognitions
Leaders in D&I, R&D, and
Social Impact & Employee Benefits
- About Lilly
Find How Lilly's Purpose Has Never
Been More Important.
- Our Impact
Learn About How We Responsibly
Grow Our Business.
- Press Releases
Search results
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Forbes· 4 days agoEli Lilly will invest an additional $5.3 billion into a new manufacturing site, boosting production...
Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
Zacks via Yahoo Finance· 16 hours agoSince 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via AOL· 7 days agoSHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 7 days agoHave a confidential tip for our reporters? China gave the greenlight to Eli Lilly & Co.’s...
...China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide Why Is Eli Lilly Stock Trading Higher...
Benzinga· 7 days agoOn Tuesday, Eli Lilly And Company LLY announced that Chinese regulators have approved its diabetes ...
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
WPRI Providence· 4 days agoEli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually...
Eli Lilly invests $9 billion to increase supply of blockbuster drugs Zepbound and Mounjaro
USA Today· 4 days agoEli Lilly and Co., is more than doubling its investment in an Indiana manufacturing site to increase...
Eli Lilly is spending billions on a new facility to make its popular weight loss drug Zepbound
Quartz· 4 days agoThe new spend brings the company’s total investment in the site to a whopping $9 billion, up from...
This new weight loss drug ETF bets big on two of the industry's leading players
CNBC· 12 hours agoRoundhill Investments' GLP-1 & Weight Loss ETF (OZEM), which began trading last week, pairs leaders ...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
NBC Washington· 6 days agoThe rivalry between Eli Lilly and Novo Nordisk extends beyond a buzzy class of weight loss and ...
Ads
related to: eli lilly diabetes drug